Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

Quick Stats
Studies 178
Trials 100
2024 pubmed 4 citations

Peak serum luteinising hormone cut-off during gonadotropin-releasing hormone analogue test for diagnosing central precocious puberty was lower in girls with obesity as compared with girls with normal weight.

Sakornyutthadej. Natee N; Mahachoklertwattana. Pat P; Wankanit. Somboon S; Poomthavorn. Preamrudee P

Key Findings

  • Peak LH levels during a triptorelin test are similar in overweight and normal‑weight girls with central precocious puberty
  • The optimal LH cut‑off for diagnosing CPP is lower (4 IU/L) in overweight/obese girls
  • Using the lower cut‑off improves sensitivity (86%) and specificity (93%) in overweight girls

Practical Outcomes

  • For clinicians treating children, adjust the LH threshold to 4 IU/L when the patient is overweight to avoid missing a diagnosis. This finding has little direct impact on adult biohacking or longevity protocols.

Summary

The study looked at how the hormone‑triggering drug triptorelin is used in a test to diagnose early puberty in girls and found that overweight girls need a lower LH cut‑off (4 IU/L) than normal‑weight girls (5 IU/L).

Abstract

Serum luteinising hormone (LH) concentration has been reported to be lower in girls with overweight and obesity (OW/OB) as compared with girls with normal weight (NW). This study aimed to evaluate peak serum LH concentration during gonadotropin-releasing hormone analogue (GnRHa) test in girls with OW/OB and NW who had central precocious puberty (CPP) and to determine peak serum LH cut-off for diagnosing CPP in girls with OW/OB. Medical records of 971 girls with premature breast development who underwent subcutaneous GnRHa (100 µg of triptorelin acetate) test were reviewed. All girls were classified as either CPP or premature thelarche. All of them were further classified into two groups according to their body mass index as NW and OW/OB groups for each Tanner stage. There were 634 and 337 girls in NW and OW/OB groups, respectively. CPP was diagnosed in 600 girls (249 had Tanner stage II and 351 had Tanner stage III). There were no differences in peak serum LH concentrations between CPP girls with NW and OW/OB. Peak serum LH cut-off of 5 IU/L (the current widely used cut-off) had a sensitivity and a specificity of 75% and 90%, respectively in NW group. Peak serum LH cut-off for CPP diagnosis was lower at 4 IU/L in the OW/OB group with greater sensitivity and specificity of 86% and 93%, respectively. The results were reproducible for each Tanner stage of breasts. Lower peak serum LH cut-off to 4 IU/L for diagnosing CPP in girls with OW/OB should be considered to avoid underdiagnosis of the condition.

Study Information

Provider

pubmed

Year

2024

Date

2024-02-01T00:00:00.000Z

DOI

10.1111/cen.15026

Citations

4

References

33